LEP and fatty liver disease: In our previous work, we studied the modulation of Endo1 at the central level, showing that its specific silencing in the ARH of mice has beneficial effects after a HFD by improving leptin sensitivity and reducing body weight, accompanied by an improvement in blood lipid parameters and liver steatosis (16).